✦ LIBER ✦

A histopathological study of the effects of 6-month versus 12-month interferon α-2b therapy in chronic hepatitis C

✍ Scribed by Marianne Ziol; Jeanne Tran Van Nhieu; Françoise Roudot-Thoraval; Jean-Michel Métreau; Yves Deugnier; Daniel Dhumeaux; Elie Serge Zafrani

Book ID: 118567459
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 673 KB
Volume: 25
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(96)80286-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insufficiency of a 6-month interferon-α2

Insufficiency of a 6-month interferon-α2b therapy in chronic hepatitis C

✍ I. Nagy; B. Velősy; Zs. Ozsvár; J. Jármay 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 145 KB

A 12 months course of interferon and lam

A 12 months course of interferon and lamivudine combination therapy versus interferon monotherapy for untreated chronic hepatitis B infection

✍ Kendal Yalcin; F. Yildiz; H. Degertekin; Y. Celik 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Better efficacy of a 12-month interferon

Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter, controlled, randomized trial

✍ Jean-Louis Payen; Jacques Izopet; Virginie Galindo-Migeot; Valérie Lauwers-Cance 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB 👁 2 views

We studied the efficacy of three interferon alfa-2b (IFN-2b) regimens for the retreatment of patients with chronic hepatitis C (CHC) with prior complete response followed by relapse. Consecutive patients with CHC who had a complete biochemical response but relapse after a first course of 6 months of

Efficacy of prolonged interferon-alpha t

Efficacy of prolonged interferon-alpha treatment in chronic hepatitis B patients with HBeAb: comparison between 6 and 12 months of therapy

✍ J. M. Lopez-Alcorocho; J. Bartolome; T. Cotonat; V. Carreño 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

Comparison of a 6-month course peginterf

Comparison of a 6-month course peginterferon α-2b plus ribavirin and interferon α-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan

✍ S.-D. Lee; M.-L. Yu; P.-N. Cheng; M.-Y. Lai; Y.-C. Chao; S.-J. Hwang; W.-Y. Chan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Pegylated interferon α2b versus pegylate

Pegylated interferon α2b versus pegylated interferon α2a for chronic hepatitis C: The unreached goal of superiority

✍ Maria Grazia Rumi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 87 KB